Literature DB >> 8669928

Vision impairment in Liverpool: prevalence and morbidity.

M Rogers1.   

Abstract

A database related to the activities of the Liverpool vision assessment team was used to identify all children with vision impairment aged 0-16 years, resident in Liverpool, UK, on 1 April 1995. Prevalence rates were calculated for all children with vision impairment, and separately for two groups: those with uncomplicated vision impairment, and those with additional pathology. Visual tract pathologies were tabulated and compared. Associated handicapping conditions were defined and the extent of multiple disability was investigated for all vision impaired children, for very low birthweight children, and for those with cortical visual impairment. Of 199 children with vision impairment, 69 (35%) had uncomplicated impairment and 130 (65%) had additional and usually multiple pathology. There were 111 boys (56%); the excess of males was not statistically significant. Prevalence rates per 10,000 population were 18.1 for all vision impairment, 6.3 for uncomplicated vision impairment, and 11.8 for vision impairment complicated by additional pathology. Genetically determined disease accounted for over half the cases of uncomplicated vision impairment. Among the 130 children with additional pathology, cortical visual impairment was the commonest visual tract finding, affecting 64 (49%); 86% had learning difficulties; 53% had cerebral palsy. Multidisability (two or more disabling conditions in addition to vision impairment) affected half the entire childhood vision impairment population. These data should assist health and education authorities to determine the size of the vision impairment problem and how it relates to other disabilities in childhood, and can facilitate resource allocation and service planning.

Entities:  

Mesh:

Year:  1996        PMID: 8669928      PMCID: PMC1511464          DOI: 10.1136/adc.74.4.299

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  The Liverpool Visual Assessment Team: 10 years' experience.

Authors:  A E Hill; O McKendrick; J J Poole; R E Pugh; L Rosenbloom; R Turnock
Journal:  Child Care Health Dev       Date:  1986 Jan-Feb       Impact factor: 2.508

Review 2.  Vision in childhood.

Authors:  C S Peckham
Journal:  Br Med Bull       Date:  1986-04       Impact factor: 4.291

3.  Screening for retinopathy of prematurity--a problem solved?

Authors:  J T Flynn; A Sola; W V Good; R H Phibbs
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

4.  Factors affecting survival and outcome at 3 years in extremely preterm infants.

Authors:  R W Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-07       Impact factor: 5.747

5.  Impact of cerebral visual impairment on the everyday life of cerebral palsied children.

Authors:  A J Schenk-Rootlieb; O Van Nieuwenhuizen; N Schiemanck; Y Van der Graaf; J Willemse
Journal:  Child Care Health Dev       Date:  1993 Nov-Dec       Impact factor: 2.508

6.  Visual impairment in Nordic children. I. Nordic registers and prevalence data.

Authors:  R Riise; T Flage; E Hansen; T Rosenberg; S L Rudanko; G Viggosson; M Warburg
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-04

Review 7.  Retinopathy of prematurity.

Authors:  D L Phelps
Journal:  Pediatr Rev       Date:  1995-02

8.  Visual impairment in Nordic children. III. Diagnoses.

Authors:  E Hansen; T Flage; T Rosenberg; S L Rudanko; G Viggosson; R Riise
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-10

9.  Visual impairment in Nordic children. IV. Sex distribution.

Authors:  R Riise; T Flage; E Hansen; T Rosenberg; S L Rudanko; G Viggosson
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-10

10.  Causes of blindness and severe visual impairment in children in Chile.

Authors:  C E Gilbert; R Canovas; R Kocksch de Canovas; A Foster
Journal:  Dev Med Child Neurol       Date:  1994-04       Impact factor: 5.449

View more
  15 in total

1.  Recent trends in visual impairment and blindness in the UK.

Authors:  Florence Bodeau-Livinec; Geraldine Surman; Monique Kaminski; Andrew R Wilkinson; Pierre-Yves Ancel; Jennifer J Kurinczuk
Journal:  Arch Dis Child       Date:  2007-08-03       Impact factor: 3.791

Review 2.  Epidemiology of visual impairment in Britain.

Authors:  J S Rahi; C Dezateux
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

3.  Cryptic cerebral visual impairment in children.

Authors:  R S Lowery; D Atkinson; S R Lambert
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

4.  Development of a quantitative method to measure vision in children with chronic cortical visual impairment.

Authors:  W V Good
Journal:  Trans Am Ophthalmol Soc       Date:  2001

5.  Mechanisms compensating for visual field restriction in adolescents with damage to the retro-geniculate visual system.

Authors:  L Jacobson; F Lennartsson; T Pansell; G Oqvist Seimyr; L Martin
Journal:  Eye (Lond)       Date:  2012-09-21       Impact factor: 3.775

6.  6,220 institutionalised people with intellectual disability referred for visual assessment between 1993 and 2003: overview and trends.

Authors:  C E D van Isterdael; J S Stilma; P D Bezemer; N T Tijmes
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

7.  Chronic cortical visual impairment in children: aetiology, prognosis, and associated neurological deficits.

Authors:  R Huo; S K Burden; C S Hoyt; W V Good
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

8.  Can routine information systems be used to monitor serious disability?

Authors:  A Johnson; R King
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

9.  Long-term visual outcomes in extremely low-birth-weight children (an American Ophthalmological Society thesis).

Authors:  Rand Spencer
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Cortical visual impairment in children - A new challenge for the future?

Authors:  Meenakshi Swaminathan
Journal:  Oman J Ophthalmol       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.